This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Bacterial vaginosis (BV) is a common gynaecological condition characterized by an imbalance in the vaginal microbiota. Bacterial Vaginosis Therapeutics Market was valued at USD 962.12 Million in 2019 and is projected to reach USD 1,697.25 Million by 2027, at a long-term CAGR of 8.70% from 2020 to 2027.
To focus more on the topic, Sciinov Group welcomes you to the fully online conference “Research & Updates on BACTERIAL VAGINOSIS” during 17-18, June, 2024.
Engage in pass...
We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables.
If you are interested in being considered as a speaker, submit your proposal/abstract Online
We let speakers propose the topic they want to talk about. This process allows speakers to propose sessions that speak from their expertise and passion.
Speaker can choose the topic of your choice in related to the conference subject or any of their recent research work to present at our conference.
For details of scientific sessions covered please visit [not limited to, you can propose]
Please visit the page here
Yes, as our conference is scheduled in Online Mode, you can present and listen to full program virtually connecting via ZOOM live stream
01 Apr
2024
Strategic Process Underway to Explore Partnering Opportunities for Additional Indications such as with GLP-1s for Obesity and Metabolic Disorders and Other Conditions Requiring Precise, Prolonged TreatmentReadmore
10 Jan
2024
Despite being the most common vaginal condition, BV symptoms are often mistaken for a yeast infectionReadmore
8 Nov
2023
Gedea Biotech developing antibiotic-free treatments, today announced that the Swedish Medical Product Agency and Ethics committee have approved the initiation of a randomized, partly-blinded investigation to evaluate the clinical performance and safety ofReadmore
12 Jul
2023
Prescribing information supports positioning of XACIATO as a first line option for the treatment of bacterial vaginosisReadmore
.jpg.jpg)
Thank you very much for the organization of such an event. I have learned a lot.
Congratulations on the great turnout at the Aging and Gerontology Conference this year!!! I really enjoyed presenting at your event
It was a great experience exchanging views on Aging with speakers from all around the world.
Good day a very nice and informative congress, most of the presentations were very interesting. As a clinical medical doctor i hope some of them can help me in my daily private practice and institutional one. Besides congratulate you for the quality of the Keynote and oral presentations.
Global
The bacterial vaginosis treatment market is segmented on the basis of treatment, dosage form, route of administration, distribution channel and end-user.
Global
By Disease Type (Anti-fungal, Anti-bacterial, Hormone), By Product (OTC, Prescription), By Region, And Segment Forecasts, 2023 - 2030
.jpeg.jpeg)
.jpeg.jpeg)
